Orchid Cellmark Consolidates Nashville Branch into Dallas Facility | GenomeWeb

NEW YORK (GenomeWeb News) – Orchid Cellmark said today that it will begin to consolidate its Nashville, Tenn., forensics testing operations into its Dallas, Texas, facility within the month.

The company expects to realize approximately $1.4 million in annual cost savings from operational efficiencies, reduction in lease and equipment expenses, and increased scalability following the consolidation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.